GENNEX · GENNEX LABORATORIES LTD. · Financials
Market Cap
2.30B INR
Shares
242.95M
Volume · Nov 13
450.99K
Avg daily vol (3M)
665.46K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.73B
+25.3%
FY2026
Net Income
185.07M
+2.1%
FY2026
Operating Cash Flow
-636.54M
-489.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 1.78B | 1.73B | 1.38B |
| INR | 27.13M | 26.48M | 19.91M |
| INR | 41.19M | 41.98M | 36.08M |
| INR | 222.88M | 232.38M | 214M |
| INR | 16.59M | 22.59M | 32.75M |
| INR | 183.78M | 185.07M | 181.25M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.